BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Chinese Patent Office
Citi
Harvard Business School
Novartis
Farmers Insurance
Express Scripts
McKesson
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,456,925

« Back to Dashboard

Summary for Patent: 5,456,925
Title: Pharmaceutical compositions containing furan derivatives
Abstract:The invention relates to a pharmaceutical composition in solid unit dosage form adapted for oral administration, comprising a salt formed between ranitidine and a complex of bismuth with a carboxylic acid selected from tartaric acid and citric acid together with an alkaline salt. For example the composition is in tablet form and comprises ranitidine bismuth citrate and sodium carbonate. The composition shows improved disintegration and/or dissolution.
Inventor(s): Smith; Norman R. (London, GB2), Heppenstall; Colin R. (Bishops Stortford, GB2), Douglas; Stephen J. (St. Albans, GB2)
Assignee: Glaxo Group Limited (Middlesex, GB)
Application Number:08/215,658
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;

Drugs Protected by US Patent 5,456,925

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,456,925

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9019875Sep 11, 1990

International Patents Family Members for US Patent 5,456,925

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ireland 913191 ➤ Subscribe
Hungary 211846 ➤ Subscribe
Canada 2050970 ➤ Subscribe
Switzerland 683068 ➤ Subscribe
Cyprus 1988 ➤ Subscribe
Germany 4130061 ➤ Subscribe
Germany 69202696 ➤ Subscribe
Denmark 159191 ➤ Subscribe
European Patent Office 0558779 ➤ Subscribe
Spain 2072647 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Cerilliant
Harvard Business School
Dow
QuintilesIMS
Julphar
Deloitte
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot